A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
Clinical trial NCT03547999 · TERMINATED
Trial details
- NCT number
- NCT03547999
- Sponsor
- Patrick Boland
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-26
- Primary completion
- 2024-03-13
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.